NCT04721717

Brief Summary

The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
11mo left

Started Sep 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Sep 2020Mar 2027

Study Start

First participant enrolled

September 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 25, 2021

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2027

Last Updated

August 8, 2025

Status Verified

August 1, 2025

Enrollment Period

6.6 years

First QC Date

December 3, 2020

Last Update Submit

August 4, 2025

Conditions

Outcome Measures

Primary Outcomes (11)

  • The Grief and Loss Scale

    (Kalpakjian et al., 2015) is a 9-item measure of an individual's emotional reactions or grief such as anger, guilt, anxiety, sadness, and despair in the past 7 days, using a 5-point scale (1=never) to 5 (always). The scores range from 9 to 45. Higher scores reflect higher degree of grief and loss.

    11 Weeks

  • Emotional Distress - Depression

    Short Form 8b. It is a part of the Patient-Reported Outcomes Measurement Information System (PROMIS). It is an 8-item measure of an individual's emotional distress (depression) in the past 7 days, using a 5-point scale (1=never) to 5 (always). The scores range from 8 to 40. Higher scores reflect higher degree of emotional distress (depression)

    11 Weeks

  • Perceived Stress Scale

    PSS) (Cohen et al. 1988) is a 10-item measure of frequency of an individual experiencing stress in the past month, using a 5-point scale (1=never) to (5=very often). Four positively stated items require reversed coding. The scores range from 10 to 50. Higher scores reflect higher frequency of experiencing stress.

    11 Weeks

  • Impact of Events Scale

    (Weiss, 2007). It is a 6-item measure of an individual's distress related to different difficulties in the past 7 days, using a 5-point scale (0=not at all) to 4 (extremely). The scores range from 0 to 24. Higher scores reflect greater distress.

    11 Weeks

  • Meaning and Purpose

    It is part of the NIH Toolbox Item Bank. It is a 7-item measure of an individual's meaning and purpose in life, using a 5-point scale (1=strongly disagree) to 5 (strongly agree). The scores range from 7 to 35. Higher scores reflect greater meaning and purpose in life.

    11 Weeks

  • Self-Efficacy for Managing Chronic Conditions - Managing Emotions

    Short Form 4a. It is a part of the Patient-Reported Outcomes Measurement Information System (PROMIS). It is a 4-item measure of an individual's self-efficacy for managing chronic conditions, using a 5-point scale (1=I am not at all confident) to 5 (I am very confident). The scores range from 4 to 20. Higher scores reflect greater confident in managing chronic conditions.

    11 Weeks

  • Sleep Disturbance

    Short Form 4a. It is a part of the Patient-Reported Outcomes Measurement Information System (PROMIS). It is a 4-item measure of an individual's sleep problem or quality in the past 7 days, using a 5-point scale (1=not at all/very much) to 5 (very much/very poor). Two positively stated item require reversed coding. The scores range from 4 to 20. Higher scores reflect greater sleep problem.

    11 Weeks

  • Sleep Impact

    Short Form. It is a part of the Adult Sickle Cell Quality of Life Measurement Information System (ASCQ). It is a 5-item measure of an individual's trouble falling asleep in the past 7 days, using a 5-point scale (1=always) to 5 (never). One positively stated item require reversed coding. The scores range from 5 to 25. Higher scores reflect less trouble falling asleep.

    11 Weeks

  • Ability to Participate in Social Roles and Activities

    Short Form 4a. It is a part of the Patient-Reported Outcomes Measurement Information System (PROMIS). It is a 4-item measure of an individual's trouble participating in social roles and activities, using a 5-point scale (1=always) to 5 (never). The scores range from 4 to 20. Higher scores reflect less trouble participating in social roles and activities.

    11 Weeks

  • Satisfaction with Social Roles and Activities

    It is a part of the Patient-Reported Outcomes Measurement Information System (PROMIS). It is a 4-item measure of an individual's satisfaction with social roles and activities, using a 5-point scale (1=not at all) to 5 (very much). The scores range from 4 to 20. Higher scores reflect greater satisfaction with social roles and activities.

    11 Weeks

  • Connor-Davidson Resilience Scale

    It consists of 10 statements that respondents rated on a 5-point scale from 0 - Not true at all. 1 - Rarely true.2 - Sometimes true.3 - Often true.4 - True nearly all the time. Answers were scored from 0 to 4 to create a total score that ranged from 0 to 100, with higher numbers denoting greater resilience.

    11 weeks

Secondary Outcomes (4)

  • Cortisol level

    11 weeks

  • Quality of Life During Serious Illness - Family Carers

    11 weeks

  • Hospital Anxiety and Depression Scale (HADS)

    11 weeks

  • Caregiver Burden Inventory

    11 weeks

Study Arms (1)

People with SCI

People with paraplegia and quadriplegia People with multiple sclerosis People with transverse myelitis Caregivers of people with amyotrophic lateral sclerosis (ALS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Sex: both Race/Ethnicity: all Age: aged 18 years or above Health status: Healthy

You may qualify if:

  • Age 18 or older with paralysis living in the community
  • limb paralysis resulting from a traumatic event/accident or neurological disease (e.g., spinal cord injury, head injury, stroke, multiple sclerosis, Transverse myelitis, poliomyelitis, peripheral neuropathy, Parkinson's disease, ALS, botulism, and Guillain-BarrĂ© syndrome etc) happened after childhood
  • a non-traumatic spinal cord injury may be caused by arthritis, cancer, inflammation, infections or disk degeneration of the spine
  • caregivers of people with amyotrophic lateral sclerosis
  • able to communicate verbally or through writing

You may not qualify if:

  • known maladaptive behavioral patterns, exhibition of overt psychotic symptoms (e.g., presence of hallucinations, delusions, or thought disorders)
  • congenital (e.g., spinal bifida, cerebral palsy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

354 School of Health Professions Building

Birmingham, Alabama, 35294, United States

RECRUITING

Related Publications (1)

  • Yuen HK, Kamp EV, Green S, Edwards L, Kirklin K, Hanebrink S, Klebine P, Han A, Chen Y. Effects of a coach-guided video-conferencing expressive writing program on facilitating grief resolution in adults with SCI. J Spinal Cord Med. 2024 Nov;47(6):1016-1025. doi: 10.1080/10790268.2023.2253390. Epub 2023 Sep 8.

Biospecimen

Retention: SAMPLES WITHOUT DNA

hair sample for cortical analysis

MeSH Terms

Conditions

Spinal Cord InjuriesMultiple SclerosisMyelitis, TransverseAmyotrophic Lateral Sclerosis

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesMyelitisCentral Nervous System InfectionsInfectionsParaneoplastic Syndromes, Nervous SystemNervous System NeoplasmsNeoplasms by SiteNeoplasmsParaneoplastic SyndromesNeurodegenerative DiseasesNeuroinflammatory DiseasesMotor Neuron DiseaseTDP-43 ProteinopathiesNeuromuscular DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Occupational Therapy

Study Record Dates

First Submitted

December 3, 2020

First Posted

January 25, 2021

Study Start

September 1, 2020

Primary Completion (Estimated)

March 28, 2027

Study Completion (Estimated)

March 28, 2027

Last Updated

August 8, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations